Bendazac L-lysine is primarily used in the treatment of cataracts, particularly in the early stages. It works by inhibiting the denaturation of lens proteins, which helps to slow down the progression of cataract formation. This makes it a valuable therapeutic agent in ophthalmology for preserving lens clarity and improving visual function. Additionally, it has anti-inflammatory properties, which can be beneficial in managing ocular inflammation associated with certain eye conditions. Its application is typically in the form of eye drops, ensuring direct delivery to the affected area for optimal efficacy.